Clinical trial

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

NCT01073228

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention EVP-6124 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE2

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Central Nervous System Diseasesunresolved

Cognitionunresolved

Interventions

EVP-6124DRUG

PlaceboDRUG

Sponsors & collaborators

FORUM Pharmaceuticals Inclead sponsor

INC Research Limitedcollaborator

Mapped research locations

BucharestRomania5 Saint PetersburgRussia4 MoscowRussia2 BrooklynNew York, United States2 KyivUkraine2 BelgradeSerbia2 DallasTexas, United States1 ColumbusOhio, United States1 PortlandOregon, United States1 PhoenixArizona, United States1 OrlandoFlorida, United States1 RochesterNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01073228 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.